home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Danny Amor's Online Library
/
Danny Amor's Online Library - Volume 1.iso
/
bbs
/
misc
/
prosite.lha
/
DATA
/
PDOC00391
< prev
next >
Wrap
Text File
|
1995-07-26
|
2KB
|
35 lines
***********************************************
* IMP dehydrogenase / GMP reductase signature *
***********************************************
IMP dehydrogenase (EC 1.1.1.205) (IMPDH) catalyzes the rate-limiting reaction
of de novo GTP biosynthesis, the NAD-dependent reduction of IMP into XMP [1].
Inhibition of IMP dehydrogenase activity results in the cessation of DNA
synthesis. As IMP dehydrogenase is associated with cell proliferation it is a
possible target for cancer chemotherapy. Mammalian and bacterial IMPDHs are
tetramer of identical chains. There are two IMP dehydrogenase isozymes in
human [2].
GMP reductase (EC 1.6.6.8) catalyzes the irreversible and NADPH-dependent
reductive deamination of GMP into IMP [3]. It functions in the conversion of
nucleobase, nucleoside and nucleotide derivatives of G to A nucleotides, and
in maintaining the intracellular balance of A and G nucleotides.
IMP dehydrogenase and GMP reductase share many regions of sequence similarity,
one of these regions is centered on a cysteine residue which is thought [3] to
be involved in the binding of IMP. We have used this region as a signature
pattern.
-Consensus pattern: [LIVM]-[RK]-[LIVM]-G-[LIVM]-G-x-G-S-[LIVM]-C-x-T
[C is the putative IMP-binding residue]
-Sequences known to belong to this class detected by the pattern: ALL.
-Other sequence(s) detected in SWISS-PROT: NONE.
-Last update: May 1991 / First entry.
[ 1] Collart F.R., Huberman E.
J. Biol. Chem. 263:15769-15772(1988).
[ 2] Natsumeda Y., Ohno S., Kawasaki H., Konno Y., Weber G., Suzuki K.
J. Biol. Chem. 265:5292-5295(1990).
[ 3] Andrews S.C., Guest J.R.
Biochem. J. 255:35-43(1988).